Add Company
Join Now

Tang Capital Management Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Tang Capital Management's estimated annual revenue is currently $3.5M per year.(i)
  • Tang Capital Management's estimated revenue per employee is $87,500

Employee Data

  • Tang Capital Management has 40 Employees.(i)
  • Tang Capital Management grew their employee count by 8% last year.

Tang Capital Management's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
Manager, Finance and AccountingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M10-55%N/AN/A
#2
N/A35-3%N/AN/A
#3
$7.5M8-27%N/AN/A
#4
$3.5M7952%N/AN/A
#5
N/A110%N/AN/A
#6
$7.5M29-12%N/AN/A
#7
$15M43-16%N/AN/A
#8
$15M34N/AN/AN/A
#9
$7.5M2624%N/AN/A
#10
$15M24518%N/AN/A
Add Company

What Is Tang Capital Management?

Tang Capital Management, LLC (Tang Capital) is a life sciences-focused investment firm with a strong track record of creating and building successful biopharmaceutical companies. The principal of Tang Capital founded Ardea Biosciences, Inc. in 2006 and served as its director until its acquisition by AstraZeneca PLC in June 2012. The principal of Tang Capital currently serves as Chairman of Heron Therapeutics, Inc. (NASDAQ: HRTX), La Jolla Pharmaceutical Company (NASDAQ: LJPC), and as the Chairman and Chief Executive Officer of Odonate Therapeutics, Inc. (NASDAQ: ODT). Tang Capital manages an investment fund that is the largest shareholder of all three of these companies. Tang Capital currently has offices in San Diego and New York.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$3.5M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.1M40-7%N/A
#2
$4.6M40-13%N/A
#3
$4.6M400%N/A
#4
$4.6M40N/AN/A
#5
$9.9M400%$10.8M